drugset / Trial / NCT05733624
Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is planned to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops(Cyclosporine 0.01%, 0.02%) compared to Restasis(Cyclosporine 0.05%) in Patients with Dry Eye Disease.
Timeline
- Start
- 2023-01-05
- Primary completion
- 2023-08-23
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.01 % | Topical |
| Subject | Cyclosporine | Peptide | 0.02 % | Topical |
| Subject | Cyclosporine | Peptide | 0.05 % | Topical |